HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin Ye Selected Research

Doxorubicin (Adriamycin)

8/2018CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy.
1/2015[Effect of Qiluxiaobai decoction on glomerular sclerosis in adriamycin-induced nephropathic rats].
1/2015Identification of CREB3L1 as a Biomarker Predicting Doxorubicin Treatment Outcome.
12/2012Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1.
8/2012[Efficacy of chemotherapy as a first-line treatment in patients with ocular adnexal MALT lymphoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin Ye Research Topics

Disease

43Neoplasms (Cancer)
04/2024 - 08/2003
12Inflammation (Inflammations)
12/2023 - 06/2008
11Infections
03/2024 - 08/2007
8Hepatocellular Carcinoma (Hepatoma)
12/2022 - 12/2003
8Lymphoma (Lymphomas)
03/2021 - 08/2003
7Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
11/2023 - 11/2016
5Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 01/2015
4Neuroinflammatory Diseases
12/2023 - 11/2020
4Carcinoma (Carcinomatosis)
07/2016 - 06/2012
3Abscess
03/2024 - 05/2021
3Cognitive Dysfunction
12/2023 - 01/2021
3Obesity
12/2023 - 11/2020
3Hepatitis B
02/2022 - 11/2012
3Hypoxia (Hypoxemia)
05/2021 - 02/2009
3Ascites
02/2020 - 05/2014
3Lymphatic Metastasis
12/2019 - 04/2012
3Asthma (Bronchial Asthma)
08/2018 - 09/2015
3Allergic Rhinitis
08/2018 - 09/2015
3Neoplasm Metastasis (Metastasis)
03/2018 - 11/2012
3Prostatic Neoplasms (Prostate Cancer)
01/2018 - 08/2010
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 10/2012
3Liver Cirrhosis (Hepatic Cirrhosis)
10/2016 - 04/2009
3Virus Diseases (Viral Diseases)
12/2013 - 01/2010
2Neurodegenerative Diseases (Neurodegenerative Disease)
03/2024 - 01/2022
2Postpartum Depression (Post-Natal Depression)
12/2023 - 11/2020
2Insulin Resistance
06/2023 - 01/2018
2Necrosis
01/2023 - 02/2014
2Spontaneous Abortion (Miscarriage)
12/2022 - 10/2014
2Stomach Neoplasms (Stomach Cancer)
04/2022 - 03/2018
2Liver Neoplasms (Liver Cancer)
01/2022 - 02/2011
2Laryngeal Neoplasms (Laryngeal Cancer)
06/2020 - 01/2016
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2019 - 01/2015
2Type 2 Diabetes Mellitus (MODY)
01/2018 - 11/2017
2Thyroid Neoplasms (Thyroid Cancer)
05/2015 - 11/2014
2Squamous Cell Carcinoma of Head and Neck
01/2013 - 04/2012
2Pathologic Complete Response
10/2012 - 08/2012

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2003
7Biomarkers (Surrogate Marker)IBA
12/2023 - 12/2012
7MicroRNAs (MicroRNA)IBA
01/2020 - 02/2011
6CholesterolIBA
12/2019 - 08/2007
6Messenger RNA (mRNA)IBA
08/2015 - 09/2005
5EnzymesIBA
01/2023 - 08/2003
5DNA (Deoxyribonucleic Acid)IBA
02/2022 - 11/2010
5Doxorubicin (Adriamycin)FDA LinkGeneric
08/2018 - 08/2012
4MetalsIBA
04/2024 - 01/2021
4Glucose (Dextrose)FDA LinkGeneric
09/2022 - 10/2016
4LipidsIBA
05/2022 - 08/2017
4Small Interfering RNA (siRNA)IBA
01/2022 - 04/2007
4Pyrrolizidine AlkaloidsIBA
07/2019 - 11/2016
4CytokinesIBA
05/2019 - 09/2015
35-dimethylaminonaphthalene-1-sulfonamideIBA
03/2024 - 05/2021
3LipopolysaccharidesIBA
03/2024 - 02/2014
3Volatile Fatty AcidsIBA
03/2024 - 11/2020
3IonsIBA
02/2024 - 11/2023
3SilicatesIBA
02/2024 - 11/2023
3C-Reactive ProteinIBA
01/2023 - 09/2007
3AlbuminsIBA
05/2021 - 01/2019
3Transcription Factors (Transcription Factor)IBA
08/2018 - 07/2011
3Therapeutic UsesIBA
08/2018 - 11/2017
3OligodeoxyribonucleotidesIBA
08/2018 - 09/2015
3Triglycerides (Triacylglycerol)IBA
08/2017 - 01/2015
2Gallic AcidIBA
04/2024 - 02/2024
2Norepinephrine (Noradrenaline)FDA LinkGeneric
03/2024 - 11/2020
2Serotonin (5 Hydroxytryptamine)IBA
03/2024 - 11/2020
2Amino AcidsFDA Link
03/2024 - 01/2022
2Oxygen (Dioxygen)IBA
02/2024 - 11/2023
2Glutathione (Reduced Glutathione)IBA
11/2023 - 01/2022
2ImmunosorbentsIBA
01/2023 - 08/2003
21-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2022 - 01/2022
2Antiviral Agents (Antivirals)IBA
02/2022 - 12/2013
2Tryptophan (L-Tryptophan)FDA Link
01/2022 - 01/2022
2Ursodeoxycholic Acid (Urso)FDA LinkGeneric
04/2021 - 04/2013
2LigandsIBA
01/2021 - 11/2009
2Vindesine (Vindesin)IBA
12/2020 - 01/2020
2Etoposide (VP 16)FDA LinkGeneric
12/2020 - 01/2020
2Dexamethasone (Maxidex)FDA LinkGeneric
12/2020 - 01/2020
2IfosfamideFDA LinkGeneric
12/2020 - 01/2020
2pegaspargase (Oncaspar)FDA Link
12/2020 - 01/2020
2Immunoglobulin G (IgG)IBA
11/2020 - 03/2010
2SterolsIBA
12/2019 - 09/2009
2oxidized low density lipoproteinIBA
12/2019 - 11/2009
2Cisplatin (Platino)FDA LinkGeneric
05/2019 - 01/2018
2Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
08/2018 - 01/2015
2OvalbuminIBA
08/2018 - 09/2015
2PlatinumIBA
03/2018 - 10/2012
2Insulin (Novolin)FDA Link
01/2018 - 01/2018
2Nonesterified Fatty Acids (NEFA)IBA
08/2017 - 10/2015
2Cadherins (E-Cadherin)IBA
03/2016 - 04/2012
2Immunoglobulin E (IgE)IBA
01/2016 - 09/2015
2Interleukin-5 (Interleukin 5)IBA
01/2016 - 09/2015
2Interleukin-4 (Interleukin 4)IBA
01/2016 - 09/2015
2Fatty Acids (Saturated Fatty Acids)IBA
04/2014 - 01/2008
2Rituximab (Mabthera)FDA Link
10/2012 - 08/2012

Therapy/Procedure

23Therapeutics
04/2024 - 03/2007
12Drug Therapy (Chemotherapy)
01/2022 - 08/2003
6Precision Medicine
02/2024 - 01/2021
5Immunotherapy
01/2018 - 01/2010
3Radiotherapy
05/2019 - 03/2016
3Intranasal Administration
08/2018 - 09/2015
2Photochemotherapy (Photodynamic Therapy)
11/2023 - 01/2022